logo

For the Inventor, By the Inventor

Ramat Gan, Israel

Haim Yellin

This inventor holds 20 USPTO granted patents, primarily in Pharmaceutical Compositions. Top assignees: Teva Pharmaceutical Industries Limited, Technion Research & Development Foundation Ltd, Astra Lakemedel Aktiebolag. Active years: 1980-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haim Yellin. Retrieved from https://idiyas.com/inventor/haim-yellin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20

% Patents Active = 95.0

Average Co-Inventor Count = 5.0

ph-index = 14

Forward Citations = 616(Granted Patents)


Company Filing History:

goldMedal18 out of 505 
 
Teva Pharmaceutical Industries Limited
 patents
silverMedal12 out of 1,004 
 
Technion Research & Development Foundation Ltd
 patents
bronzeMedal1 out of 68 
 
Astra Lakemedel Aktiebolag
 patents
4. 1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1980-2005

Loading Chart...
Areas of Expertise:
R-Enantiomer
N-Propargyl-1-Aminoindan
Dementia Treatment
Pharmaceutical Compositions
Memory Disorders
Stable Solutions
Biocidal Compositions
Ethoxycarbonyl Esters
Injectable Solutions
Vinca Dimer Salts
20 patents (USPTO):Explore Patents
1. 6956060 - Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof (2005-10-18),
2. 6316504 - Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof (2001-11-13),
3. 5891923 - R-enantiomer of N-propargyl-1-aminoindan for the treatment of dementia (1999-04-06),
4. 5786390 - Pharmaceutical compositions of the R-enantiomer of N-propargyl (1998-07-28),
5. 5744500 - Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions (1998-04-28),
6. 5668181 - Use of the R-enantiomers of N-propargyl-1-aminoindan compounds for the (1997-09-16),
7. 5599991 - Esylate and sulfate salts of R(+)-N-propargyl-1-aminoindan (1997-02-04),
8. 5576353 - Method of treating memory disorders using R-enantiomers of (1996-11-19),
9. 5532415 - R-enantiomer of N-propargyl-1-aminoindan, salts, compositions and uses (1996-07-02),
10. 5519061 - R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses (1996-05-21),
11. 5457133 - R-enantiomers of N-propargyl-aminoindan compounds, their preparation and (1995-10-10),
12. 5453446 - Use of the R-enantiomers of N-propargyl 1-aminoindan compounds for (1995-09-26),
13. 5387612 - Use of the R-enantiomers of N-propargyl-1-aminoindan compounds for (1995-02-07),
14. 4889929 - Preparation of 1'-ethoxycarbonyl-oxyethyl esters of penicillins (1989-12-26),
15. 4889724 - Stable aqueous cisplatin solutions (1989-12-26),

Title: The Innovative Journey of Haim Yellin

Introduction: Haim Yellin, a pioneering inventor hailing from Ramat-Gan, Israel, has made significant contributions to the world of innovations and patents with his groundbreaking ideas and creations.

Latest Patents: Haim Yellin's latest patents showcase his commitment to pushing the boundaries of technology and creativity, with a focus on improving everyday life through his inventions.

Career Highlights: Throughout his illustrious career, Haim Yellin has been recognized for his inventive spirit and dedication to transforming ideas into tangible solutions. His work has garnered acclaim in various industries, solidifying his reputation as a visionary inventor.

Collaborations: Haim Yellin has collaborated with leading research institutions, universities, and innovative companies to bring his ideas to life. His partnerships have been instrumental in turning his concepts into reality and bringing about positive change in the world.

Conclusion: In conclusion, Haim Yellin's passion for innovation, coupled with his relentless drive to create, has established him as a prominent figure in the realm of inventions and patents. His contributions continue to inspire future generations of inventors to think outside the box and pursue their creative visions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…